- Home
- FRGE vs LXEO Comparison
FRGE vs LXEO Comparison
Compare FRGE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRGE | LXEO |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 620.1M | 731.3M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FRGE | LXEO |
|---|---|---|
| Price | $44.69 | $7.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $31.00 | $18.60 |
| AVG Volume (30 Days) | 145.3K | ★ 1.3M |
| Earning Date | 03-04-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,884,000.00 | N/A |
| Revenue This Year | $33.10 | N/A |
| Revenue Next Year | $24.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.40 | N/A |
| 52 Week Low | $6.60 | $1.45 |
| 52 Week High | $44.88 | $10.99 |
Technical Indicators
Market Signals| Indicator | FRGE | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 64.46 | 37.88 |
| Support Level | $44.50 | $7.24 |
| Resistance Level | $44.70 | $7.75 |
| Average True Range (ATR) | 0.11 | 0.60 |
| MACD | -0.14 | -0.03 |
| Stochastic Oscillator | 70.37 | 16.30 |
Price Performance
Historical ComparisonAbout FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.